Blood‐based Proteomic Profiling for the Progression of Cognitive Decline, Neuropsychiatric Symptomatology, and Neuroimaging Outcomes within an Asian Memory Clinic Cohort
Ming Ann Sim, Hyung Won Choi, Yuan Cai, Arthur Mark Richards, Christopher Chen · 2025
Read Blood‐based Proteomic Profiling for the Progression of Cognitive Decline, Neuropsychiatric Symptomatology, and Neuroimaging Outcomes within an Asian Memory Clinic Cohort by Ming Ann Sim, Hyung Won Choi, Yuan Cai, Arthur Mark Richards, Christopher Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712298.txt.
Description
Ming Ann Sim and four co-authors test whether proteins in blood can forecast decline in patients of a Singapore memory clinic. Their 2025 study followed 528 attendees for four years, with yearly checks of thinking and mood and brain scans every two years. At the start, blood was screened for 1,536 proteins across all major body pathways.
About a third of the group declined in thinking over the follow-up. The team found 245 proteins linked to that decline; two stood out, GFAP and NEFL, both tied to brain cell injury. The study also tracked mood symptoms, small vessel disease in the brain, and shrinkage of the memory hub. Protein profiles from one blood draw, the authors argue, could help clinics plan who needs close watch. The cohort's high rate of vessel disease makes it a hard test case.
Catalog record
| CREATOR | Ming Ann Sim, Hyung Won Choi, Yuan Cai, Arthur Mark Richards, Christopher Chen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |